Abbott’s Zika virus test given FDA authorisation
February 7, 2017Manufacturing and Production, Research and Development Abbott Laboratories, Zika virus
The threat of the Zika virus, though it may have disappeared from the headlines, is still very much present. Any …
Thomas Cueni named as new IFPMA Director General
February 7, 2017Manufacturing and Production IFPMA
Thomas Cueni has become the new Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and will …
Teva’s CEO merry-go-round continues as Vigodman leaves
February 7, 2017Manufacturing and Production, Medical Communications Teva, erez vigodman
Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …
MSD aims to get the jump on BMS treating bladder cancer
February 6, 2017Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, MSD, keytruda, opdivo
Bristol-Myers Squibb’s Opdivo was only just approved for second-line treatment of bladder cancer, but MSD has attempted to have its …
Sanofi reinforces senior staff with two new execs
February 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi
Sanofi has reinforced its senior staff with a double-whammy of appointments; firstly, the French firm has announced that it is …
Medherant appoints new Chairman
February 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medherant
Medherant has brought in Dr Ken Cunningham as Chair in a bid to strengthen the company as it moves into …
J&J breast implants “may have harmed thousands”, claims fresh lawsuit
February 6, 2017Sales and Marketing J&J, JJ, Mentor Worldwide, breast implants
Mentor Worldwide, a unit of US pharma firm Johnson & Johnson, has been accused of selling defective breast implants and …
FDA clears Opdivo to treat most common form of bladder cancer
February 6, 2017Sales and Marketing BMS, Bristol-Myers Squibb, MSD, bladder cancer, immunotherapy, keytruda, opdivo
Bristol-Myers Squibb’s Opdivo has acquired another indication – being given the go-ahead for treatment of patients with metastatic urothelial carcinoma. …
Socially vigilant: Does pharmacovigilance need secondary data & social media?
February 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, pharmacovigilance
As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new …
Link discovered between immune system genes and leukaemia
February 6, 2017Research and Development, Sales and Marketing Bloodwise, ICR, leukaemia
Research coming out of The Institute of Cancer Research, and funded by charity Bloodwise, has found that people who inherit …
Phase 2 failure for Innate Pharma leukaemia drug
February 6, 2017Research and Development, Sales and Marketing Innate Pharma, leukaemia, lirilumab
Lirilumab, Innate Pharma’s acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …
10% of UK left with no out-of-hours GP cover during 2016
February 6, 2017Medical Communications, Sales and Marketing
A freedom of information request, by Pulse, led to the discovery that 1 in 10 areas in the UK were …
Cancer rates set to rocket in women six times faster than men
February 3, 2017Medical Communications, Research and Development Cancer, Cancer Research UK, World Cancer Day
The figures emerging from research conducted by Cancer Research UK predict that rates of cancer in women will rise by …
Takeda discusses the importance of patient-focused market access
February 3, 2017Medical Communications, Sales and Marketing Takeda, oncology
With World Cancer Day on 4 February, Takeda Oncology’s Liviu Niculescu and Stephen J. Noga talk to Pharmafile.com on the …
Top Ten most popular articles on Pharmafile.com this week
February 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Moving into February,and the first weeks of Trump’s term, the US President has dominated the headlines in the industry as …
Study reveals antidepressant medication’s action upon brain
February 3, 2017Medical Communications, Research and Development antidepressants, mental health, research
With levels of antidepressant prescription rising coupled with the lack of development and investment in new treatments, further research into …
WCO seizes 113m fake Indian & Chinese drugs in Africa in 10 days
February 3, 2017Manufacturing and Production, Medical Communications, Sales and Marketing Africa, China, Counterfeit drugs, India, World Customs Organisation
The World Customs Organisation (WCO) has revealed insight into the extent of the global drug counterfeiting crisis with the announcement …
NICE rejects Pfizer’s first-in-class breast cancer drug
February 3, 2017Medical Communications, Sales and Marketing NICE, Pfizer, breast cancer
NICE has published draft guidelines which reject Pfizer’s Ibrance (palbociclib) based primarily on the cost of the drug but also …
Cirrus ready for serialisation pack changes
February 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cirrus, Multi Packaging Solutions
Cirrus, a Multi Packaging Solutions company, offers a full artwork management service ahead of enforced pack changes due to impending …
More at risk of sudden death due to faulty heart gene than thought
February 2, 2017Medical Communications, Research and Development British Heart Foundation, faulty gene, sudden death
The British Heart Foundation has revealed that around 620,000 people are thought to be at risk of having a faulty …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
